After Legalization, Cannabis Got Stronger, ER Visits Rose, and Risk Perception Dropped

This review synthesized what had been observed in jurisdictions that legalized recreational cannabis and found a consistent pattern: potency increased as commercial producers optimized for THC content, cannabis-related emergency department visits rose, and public perception of risk declined — particularly among young people.

The authors argued that legalization frameworks had primarily focused on market economics — creating legal supply chains, diverting profits from illegal markets, and reducing prohibition costs — while underweighting health and safety considerations. The language around commercial cannabis tended to trivialize risk, and increased visibility in public spaces contributed to normalization.

The paper called for regulation models that prioritized individual health and safety alongside market goals, including potency limits, restrictions on marketing, and better public education about dose-dependent risks.

This paper captured the gap between the promise of legalization and its early implementation. Legal cannabis was supposed to be safer cannabis — regulated, tested, labeled. But in practice, the market pushed potency higher (because that's what sells), risk perception dropped (because legal equals safe in many people's minds), and ER visits increased.

None of this means legalization was wrong. It means the regulatory frameworks weren't designed with health outcomes as the primary goal. The alcohol parallel is instructive: alcohol is legal, but its regulation has evolved over decades to include advertising restrictions, age limits, taxation, and impaired driving laws. Cannabis regulation was still in its early stages.